AGSW(600199)2024-04-15 09:51Revenue Performance - The company achieved total operating revenue of RMB 146,942.74 million, an increase of 23.92% compared to the previous year[7]. - The white liquor sales revenue reached RMB 98,206.31 million, growing by 43.43% year-on-year, while pharmaceutical sales revenue decreased by 13.59% to RMB 41,710.19 million[9]. Profitability - Operating profit improved to -RMB 499.15 million, a 97.10% increase from the previous year's loss[9]. - Total profit amounted to RMB 344.63 million, marking a 102.07% increase compared to the previous year[9]. - The net profit attributable to shareholders was -RMB 2,206.96 million, an improvement of 88.21% year-on-year[9]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -RMB 5,742.52 million, up 72.10% from the previous year[9]. - Basic earnings per share improved to -RMB 0.03, an increase of 89.29% compared to the previous year[9]. Assets and Equity - Total assets at the end of the reporting period were RMB 347,625.72 million, a 2.41% increase from the beginning of the period[18]. - Shareholders' equity attributable to the parent company decreased by 1.02% to RMB 251,913.19 million[18]. Management Reforms - The company implemented management reforms in five areas, leading to significant improvements in performance and cost control[2].